文献速递其他结缔组织病

转录组分析揭示免疫检查点抑制剂诱导性肌炎的 distinct 亚群

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
PubMed 文献 · Ann Rheum Dis · 2023-02-17

对200份肌肉活检(35例ICI-肌炎、44例DM、18例AS、54例IMNM、16例IBM、33份正常肌肉活检)行bulk RNA测序,对22份活检行单核RNA测序。无监督聚类定义ICI-肌炎三个转录组亚群:ICI-DM、ICI-MYO1、ICI-MYO2。ICI-MYO1包含所有发生共存心肌炎的患者;三个亚群均过表达IL6通路基因,I型干扰素通路激活为ICI-DM特异性,II型IFN通路在ICI-DM和ICI-MYO1过表达。

要点

  • ICI-肌炎可分为ICI-DM、ICI-MYO1、ICI-MYO2三个转录组亚群
  • ICI-MYO1高度炎症性且包含所有发生共存心肌炎的患者
  • 三个ICI-肌炎亚群均过表达IL6通路基因

核心结论

  • 基于转录组分析鉴定出三种不同的ICI-肌炎类型,IL6通路在所有组中过表达,I型干扰素通路激活为ICI-DM特异性,II型IFN通路在ICI-DM和ICI-MYO1中过表达,仅ICI-MYO1患者发生心肌炎。

研究设计与样本

  • 对200份肌肉活检(35例ICI-肌炎、44例DM、18例AS、54例IMNM、16例IBM和33份正常肌肉活检)行bulk RNA测序。
  • 对22份肌肉活检(7例ICI-肌炎、4例DM、3例AS、6例IMNM和2例IBM)行单核RNA测序。

主要发现

  • 无监督聚类定义ICI-肌炎的三个不同转录组亚群:ICI-DM、ICI-MYO1和ICI-MYO2。
  • ICI-DM包括伴有DM和抗TIF1γ自身抗体的患者,这些患者与DM患者一样过表达1型干扰素诱导基因。
  • ICI-MYO1患者肌肉活检呈高度炎症性,并包括所有发生共存心肌炎的患者。
  • ICI-MYO2由以坏死性病理为主且肌肉炎症水平低的患者组成。
  • II型干扰素通路在ICI-DM和ICI-MYO1中均被激活;与其他类型肌炎不同,所有三个ICI-肌炎亚群患者均过表达参与IL6通路的基因。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Inflammatory myopathy or myositis is a heterogeneous family of immune-mediated diseases including dermatomyositis (DM), antisynthetase syndrome (AS), immune-mediated necrotising myopathy (IMNM) and inclusion body myositis (IBM). Immune checkpoint inhibitors (ICIs) can also cause myositis (ICI-myositis). This study was designed to define gene expression patterns in muscle biopsies from patients with ICI-myositis. METHODS: Bulk RNA sequencing was performed on 200 muscle biopsies (35 ICI-myositis, 44 DM, 18 AS, 54 IMNM, 16 IBM and 33 normal muscle biopsies) and single nuclei RNA sequencing was performed on 22 muscle biopsies (seven ICI-myositis, four DM, three AS, six IMNM and two IBM). RESULTS: Unsupervised clustering defined three distinct transcriptomic subsets of ICI-myositis: ICI-DM, ICI-MYO1 and ICI-MYO2. ICI-DM included patients with DM and anti-TIF1γ autoantibodies who, like DM patients, overexpressed type 1 interferon-inducible genes. ICI-MYO1 patients had highly inflammatory muscle biopsies and included all patients that developed coexisting myocarditis. ICI-MYO2 was composed of patients with predominant necrotising pathology and low levels of muscle inflammation. The type 2 interferon pathway was activated both in ICI-DM and ICI-MYO1. Unlike the other types of myositis, all three subsets of ICI-myositis patients overexpressed genes involved in the IL6 pathway. CONCLUSIONS: We identified three distinct types of ICI-myositis based on transcriptomic analyses. The IL6 pathway was overexpressed in all groups, the type I interferon pathway activation was specific for ICI-DM, the type 2 IFN pathway was overexpressed in both ICI-DM and ICI-MYO1 and only ICI-MYO1 patients developed myocarditis.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Pinal-Fernandez I, Quintana A, Milisenda JC, et al. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis. Ann Rheum Dis. 2023. PMID: 36801811. doi:10.1136/ard-2022-223792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。